Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Nadezhda Vasilyeva: Shifting the Boundaries of Acute Ischemic Stroke Management
Sep 1, 2026, 17:51

Nadezhda Vasilyeva: Shifting the Boundaries of Acute Ischemic Stroke Management

Nadezhda Vasilyeva, Neurologist, shared a post on LinkedIn:

The boundaries of acute ischemic stroke management are shifting: the 2026 AHA/ASA guidance allows tenecteplase 0.25 mg/kg as an alternative to alteplase within 4.5 hours or less; concurrently, trials (e.g. HOPE) are investigating selective thrombolysis expansion to 4.5-24 hours using perfusion-based selection.

Antithrombotic management after reperfusion remains a trade-off: ATIS‑NVAF data showed increased bleeding without clear clinical benefit when combining anticoagulants and antiplatelets.

The emergence of Factor XIa inhibitors (e.g. asundexian; Phase III OCEANIC‑STROKE) shows reduced recurrence with an acceptable bleeding profile – potentially addressing a key neuro-safety dilemma.

As a clinician with 5+ years in neurology, I translate this bedside experience into rigorous ICH‑GCP safety monitoring.

Colleagues in research teams – how are you adapting monitoring systems for extended thrombolysis windows and new antithrombotic combinations?”

Nadezhda Vasilyeva

Stay updated with Hemostasis Today.